Research Groups and R&D Platforms: Diagnostics, Personalized medicine
Research Group:
Computational Biomedicine and Bioinformatics
Laura Elo
laura.elo[at]utu.fi
Turku Bioscience Centre,
University of Turku
Autoimmune diseases, Bioinformatics, Biomarker, Biomedicine, Cancer, Cardiovascular diseases, Data mining, Diabetes, Diagnostics, Epigenomics, Genomics, Imaging, Machine learning, Metabolic diseases, Molecular diagnostics, Next-generation sequencing, Pattern recognition, Personalized medicine, Proteomics, Systems Biology, Target discovery
Research Group:
BioNanoMaterials research group
Jessica Rosenholm
Jessica.rosenholm[at]abo.fi
Pharmaceutical Sciences Laboratory,
Åbo Akademi University
Pharmaceutical Sciences Laboratory
Antibacterial, Biomedicine, Biopharmaceuticals, Biotechnology, Cancer, Diagnostics, Drug delivery, Drug solubility, Drug stability, Electron microscopy, Fluorescence spectroscopy, Formulation, FTIR or RAMAN spectroscopy, Imaging software, Infection, Lead optimization, Musculoskeletal disorders, Nanoparticles, Natural products, Organic compounds, Particle morphology, Particle size analysis, Personalized medicine, Pharmacy, Physico-chemical properties, Porosity, Powder flow characterization, Powder X-ray diffraction, Preclinical development, Screening, Skin diseases, Super-resolution imaging, Surface area, Synthetic chemistry, Thermal analysis, Zeta potential
Research Group:
Drug Discovery and Diagnostics tools and detection methods
Harri Härmä
harri.harma[at]utu.fi
Analytical Chemistry,
University of Turku
Antibodies, Assay development, Biomarker, Biomedicine, Biomolecular chemistry, Biotechnology, Clinical Chemistry, Diagnostics, Drug target, Fluorescence spectroscopy, FTIR or RAMAN microscopy, FTIR or RAMAN spectroscopy, In Vitro Diagnostics, Molecular diagnostics, Nanoparticles, Next-generation sequencing, Nucleic acids, Particle size analysis, Pattern recognition, Personalized medicine, Receptor, Screening, Signaling, Thermal analysis
Research Group:
New tools to target harmful inflammations and cancer
Sirpa Jalkanen
sirjal[at]utu.fi
Institute of Biomedicine,
University of Turku
Cell Trafficking in Cancer and Inflammation
Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biopharmaceuticals, Breast cancer, Cancer, Cardiovascular diseases, Clinical Medicine, Colorectal cancer, Diagnostics, Disease models, Drug target, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Lung cancer, Melanoma, Metabolic diseases, Molecular Cell Biology, Molecular diagnostics, Musculoskeletal disorders, Neurological disorders, Obesity, Ovarian cancer, Pathology, Personalized medicine, PET, Prostate cancer, Receptor, Signaling, Skin diseases, Squamous cell carcinoma, Target discovery
Research Group:
Prognostic features in triple-negative breast carcinoma
Pauliina Kronqvist
paukro[at]utu.fi
Institute of Biomedicine,
University of Turku
Biomarker, Breast cancer, Cancer, Data mining, Diagnostics, Genomics, Imaging, Molecular diagnostics, Next-generation sequencing, Pathology, Personalized medicine, Point of care
Research Group:
Biomedical Epigenomics
Riikka Lund
riikka.lund[at]utu.fi
Biomedical Epigenomics Group,
Turku Bioscience Centre,
University of Turku
Ageing-related diseases, Basic research, Biomarker, Biomedicine, Biotechnology, Data mining, Diagnostics, Disease models, Drug target, Epigenomics, Genetics, Genomics, Imaging, Molecular Biology, Molecular Cell Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Target discovery
